AHR and dermatitis: Tapinarof is a novel, first‐in‐class, small molecule topical therapeutic aryl hydrocarbon receptor (AhR)‐modulating agent that binds and activates AhR, reduce skin inflammation, normalize the skin barrier, reduce oxidative stress and regulate gene expression in immune cells.6